Honeywell introduces Aclar Accel barrier film with faster production and delivery for pharma packaging.
Courtesy Honeywell
Honeywell’s Aclar Accel is a new, cost-effective thermoformable barrier film for pharmaceutical packaging that provides faster service to companies at a lower cost while maintaining barrier protection, the company said in a Feb. 6, 2019 press release. The films are available in clear and opaque laminated options, with two standard thicknesses that offer shorter lead times.
While the original Aclar is clear and customizable, Aclar Accel 1700 maintains the clarity, but has a standard size that allows for faster production and delivery to companies at a lower cost. Aclar Accel 5400 is designed for opaque laminates and offers a denser, moisture-rich barrier to companies seeking a more cost-effective solution than cold-form foil in aluminum blister packaging, which has higher production costs and slower output.
“Pharmaceutical companies are seeking new packaging technologies that allow them to get their drugs to market faster and reduce operational costs, and Aclar Accel addresses those needs,” said Ken West, vice-president and general manager, Packaging & Composites, at Honeywell, in the press release. “Companies have trusted Aclar for more than 40 years to provide the highest quality protection for their drugs and Aclar Accel gives them new choices. Now, in addition to the customized options of the original Aclar, they can select standard sizes for packaging with these new films and receive them in half the time.”
Aclar films are based on polychlorotrifluoroethylene fluoropolymers. They are clear, biochemically inert, chemical-resistant, nonflammable, and plasticizer- and stabilizer-free.
Source: Honeywell
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.